Pluri 주식 가격. PLUR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

5.35

매수가

5.35

매도가

5.85

거래량

6,475

5.35 일간 변동폭 5.69

3.7728 52주 범위 8.48

market_cap

29.265M

전일 종가

5.45

개장가

5.69

최근 거래 시간

5.35

마지막 거래 시간

재정 규모

US$ 35,774

VWAP

5.525

평균 볼륨(3m)

20,977

발행 주식

5,470,163

배당수익률

주가수익률

-1.41

주당순이익(EPS)

-3.82

매출

326k

순이익

-20.89M

Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. Th... Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.pluristem.com

본부

Haifa, North, Isr

설립됨

Pluri Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker PLUR. The last closing price for Pluri was US$5.45. Over the last year, Pluri shares have traded in a share price range of US$ 3.7728 to US$ 8.48.

Pluri currently has 5,470,163 shares in issue. The market capitalisation of Pluri is US$29.81 million. Pluri has a price to earnings ratio (PE ratio) of -1.41.

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

The Israel Innovation Authority will fund Pluri and BIRAD's collaboration to advance MAIT Cell Therapy, led by Professor Cyrille Cohen, Head of the laboratory of tumor immunology and immunotherapy...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.81	17.8414096916	4.54	6.14	4.54	75448	5.46064693	CS
4	0.73	15.8008658009	4.62	6.14	4.24	33864	5.09388227	CS
12	0.47	9.63114754098	4.88	6.18	4.24	20977	5.18457969	CS
26	-0.84	-13.5702746365	6.19	6.72	4.24	12974	5.30254667	CS
52	0.5332	11.0695897691	4.8168	8.48	3.7728	49829	5.73795807	CS
156	-2.65	-33.125	8	11.5784	3.4488	59136	6.41711048	CS
260	-2.65	-33.125	8	11.5784	3.4488	59136	6.41711048	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	US$ 0.44 (25.71%)	139.46M